Novavax reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
AstraZeneca AZN:LN USD 23.68B 3.47B
Astrazeneca AZN:US USD 23.68B 3.47B
Genocea Biosciences GNCA:US USD 2.95M 1.2M
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Mannkind MNKD:US USD 367.5M 509K
Moderna Inc MRNA:US USD 922M 281M
Novartis NVS:US USD 21.24B 2.55B
Peregrine Pharmaceuticals PPHM:US USD 141.8M 130K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Tg Therapeutics TGTX:US USD 70.04M 1.09M